These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2905784)

  • 1. Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret.
    Barnes JM; Barnes NM; Costall B; Naylor RJ; Tattersall FD
    Neuropharmacology; 1988 Aug; 27(8):783-90. PubMed ID: 2905784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The actions of fenfluramine and interaction with 5-HT3 receptor-antagonists to inhibit emesis in the ferret.
    Costall B; Naylor RJ; Tattersall FD
    J Pharm Pharmacol; 1990 Feb; 42(2):94-101. PubMed ID: 1972409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.
    Higgins GA; Kilpatrick GJ; Bunce KT; Jones BJ; Tyers MB
    Br J Pharmacol; 1989 May; 97(1):247-55. PubMed ID: 2720310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-independent model of cisplatin-induced emesis in the ferret.
    Rudd JA; Cheng CH; Naylor RJ
    Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret.
    Costall B; Domeney AM; Naylor RJ; Owera-Atepo JB; Rudd JA; Tattersall FD
    Neuropharmacology; 1990 May; 29(5):453-62. PubMed ID: 1972549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced emesis in the Ferret: a new animal model.
    Florczyk AP; Schurig JE; Bradner WT
    Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret.
    Rudd JA; Naylor RJ
    Eur J Pharmacol; 1997 Mar; 322(1):79-82. PubMed ID: 9088874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
    Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
    Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.
    Costall B; Domeney AM; Naylor RJ; Tattersall FD
    Neuropharmacology; 1987 Sep; 26(9):1321-6. PubMed ID: 2890117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenfluramine and brain transmitters in the obese Zucker rat.
    Orosco M; Bremond J; Jacquot C; Cohen Y
    Neuropharmacology; 1984 Feb; 23(2A):183-8. PubMed ID: 6201773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of the stereoisomers of fenfluramine on the acetylcholine content of rat striatum, hippocampus and nucleus accumbens.
    Consolo S; Ladinsky H; Forloni GL; Tirelli AS; Garattini S
    J Pharm Pharmacol; 1980 Mar; 32(3):201-3. PubMed ID: 6103937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients.
    Alfieri AB; Cubeddu LX
    Br J Cancer; 1995 Mar; 71(3):629-32. PubMed ID: 7533519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of para-chlorophenylalanine on brain concentration of monoamines in a bird species.
    Mexicano G; Rojas P; Rios C; Ayala-Guerrero F
    Proc West Pharmacol Soc; 1994; 37():125-7. PubMed ID: 7984642
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible involvement of the septo-hippocampal cholinergic and raphe-hippocampal serotonergic activations in the penile erection induced by fenfluramine in rats.
    Maeda N; Matsuoka N; Yamaguchi I
    Brain Res; 1994 Aug; 652(2):181-9. PubMed ID: 7953728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
    Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
    Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of reserpine, para-chlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on the head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice.
    Nakamura M; Fukushima H
    J Pharm Pharmacol; 1978 Apr; 30(4):254-6. PubMed ID: 24719
    [No Abstract]   [Full Text] [Related]  

  • 17. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.
    Hawthorn J; Ostler KJ; Andrews PL
    Q J Exp Physiol; 1988 Jan; 73(1):7-21. PubMed ID: 3347698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The actions of fentanyl to inhibit drug-induced emesis.
    Barnes NM; Bunce KT; Naylor RJ; Rudd JA
    Neuropharmacology; 1991 Oct; 30(10):1073-83. PubMed ID: 1661861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.